HCMT
PRQR icon

Highland Capital Management (Texas)’s ProQR Therapeutics PRQR Stock Holding History

Highland Capital Management (Texas)’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-256,596
Closed -$1.71M – 328
2016
Q3 		$1.71M Buy
256,596
+103,379
+67% +$569K 0.05% 176
2016
Q2 		$741K Sell
153,217
-55,692
-27% -$286K 0.03% 196
2016
Q1 		$1.02M Sell
208,909
-138,548
-40% -$704K 0.05% 166
2015
Q4 		$3.02M Sell
347,457
-47,600
-12% -$547K 0.1% 155
2015
Q3 		$5.76M Buy
395,057
+222,716
+129% +$3.73M 0.17% 136
2015
Q2 		$2.87M Sell
172,341
-11,159
-6% -$210K 0.06% 183
2015
Q1 		$4.01M Sell
183,500
-26,324
-13% -$544K 0.08% 159
2014
Q4 		$4.55M Sell
209,824
-29,507
-12% -$448K 0.15% 107
2014
Q3 		$4.11M Buy
+239,331
New +$3.83M 0.15% 122

Other funds holding PRQR

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.72B AUM 7.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Highland Capital Management (Texas)'s PRQR Position: Q4 2016 in Review

Highland Capital Management (Texas) sold out of ProQR Therapeutics (PRQR) in Q4 2016, closing a stake of 256,596 shares — an estimated $1.71M sold.

Highland Capital Management (Texas) first reported a position in PRQR in Q3 2014 and held it in 9 quarters. The position peaked at $5.76M in Q3 2015. 23 funds tracked by Wall St. Rank hold PRQR as of Q4 2016.

  • Highland Capital Management (Texas) reported no remaining ProQR Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 256,596 ProQR Therapeutics shares in Q4 2016, an estimated $1.71M.
  • Highland Capital Management (Texas) first reported a position in ProQR Therapeutics in Q3 2014 and held it in 9 quarters.
  • Highland Capital Management (Texas)'s ProQR Therapeutics position peaked at $5.76M in Q3 2015.
  • 23 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q4 2016.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2016, filed 13 Feb 2017.